BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36157456)

  • 21. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of islet cell function, insulin sensitivity, and incretin axis between Asian-Indians with either impaired fasting glucose or impaired glucose tolerance, and normal healthy controls.
    Roy A; Kamalanathan S; Sahoo J; Kar SS; Naik D; Narayanan N; Merugu C; Patel D
    Diabetes Res Clin Pract; 2021 Jun; 176():108846. PubMed ID: 33951481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance.
    Stinson SE; Fernández de Retana Alzola I; Brünner Hovendal ED; Lund MAV; Fonvig CE; Holm LA; Jonsson AE; Frithioff-Bøjsøe C; Christiansen M; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Hartmann B; Holm JC; Hansen T
    J Clin Endocrinol Metab; 2024 May; 109(6):1590-1600. PubMed ID: 38087928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
    Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
    Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
    Foghsgaard S; Vedtofte L; Andreasen C; Andersen ES; Bahne E; Bagger JI; Svare JA; Holst JJ; Clausen TD; Mathiesen ER; Damm P; Knop FK; Vilsbøll T
    Diabetologia; 2017 Jul; 60(7):1344-1353. PubMed ID: 28364253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta cell function, incretin hormones, and incretin effect in obese children and adolescents with prediabetes.
    Sakornyutthadej N; Mahachoklertwattana P; Chanprasertyothin S; Pongratanakul S; Khlairit P; Poomthavorn P
    Pediatr Diabetes; 2022 Mar; 23(2):203-211. PubMed ID: 34913553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on correlation of glucagons, type 2 diabetes and impaired glucose regulation].
    Xu T; Shi M; Qiu YX; Wang YG
    Zhongguo Zhong Yao Za Zhi; 2014 Jun; 39(12):2356-63. PubMed ID: 25244775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.
    Ghosh I; Mukhopadhyay P; Das K; Anne M B; Ali Mondal S; Basu M; Nargis T; Pandit K; Chakrabarti P; Ghosh S
    J Diabetes; 2021 Jun; 13(6):506-511. PubMed ID: 33247879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
    Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
    Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Incretin Hormones After Orthotopic Liver Transplantation.
    Gámán G; Sárváry E; Gelley F; Doros A; Görög D; Fehérvári I; Kóbori L; Wágner L; Máthé Z; Nemes B
    Transplant Proc; 2015 Sep; 47(7):2207-9. PubMed ID: 26361681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects.
    Paniagua JA; de la Sacristana AG; Sánchez E; Romero I; Vidal-Puig A; Berral FJ; Escribano A; Moyano MJ; Peréz-Martinez P; López-Miranda J; Pérez-Jiménez F
    J Am Coll Nutr; 2007 Oct; 26(5):434-44. PubMed ID: 17914131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
    Junker AE; Gluud L; Holst JJ; Knop FK; Vilsbøll T
    J Intern Med; 2016 May; 279(5):485-93. PubMed ID: 26728692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials.
    Wu S; Gao L; Cipriani A; Huang Y; Yang Z; Yang J; Yu S; Zhang Y; Chai S; Zhang Z; Sun F; Zhan S
    Diabetes Obes Metab; 2019 Apr; 21(4):975-983. PubMed ID: 30536884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher insulin and glucagon-like peptide-1 (GLP-1) levels in healthy, young South Asians as compared to Caucasians during an oral glucose tolerance test.
    Sleddering MA; Bakker LE; Janssen LG; Meinders AE; Jazet IM
    Metabolism; 2014 Feb; 63(2):226-32. PubMed ID: 24290838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.